IN2013CH05270A - - Google Patents

Download PDF

Info

Publication number
IN2013CH05270A
IN2013CH05270A IN5270CH2013A IN2013CH05270A IN 2013CH05270 A IN2013CH05270 A IN 2013CH05270A IN 5270CH2013 A IN5270CH2013 A IN 5270CH2013A IN 2013CH05270 A IN2013CH05270 A IN 2013CH05270A
Authority
IN
India
Prior art keywords
pharmaceutical composition
topical pharmaceutical
nepafenac
suspendable
pharmaceutically acceptable
Prior art date
Application number
Other languages
English (en)
Inventor
Rajesh Kshirsagar
Sachin Mundade
Shambulingappa
Original Assignee
Micro Labs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micro Labs Ltd filed Critical Micro Labs Ltd
Priority to IN5270CH2013 priority Critical patent/IN2013CH05270A/en
Publication of IN2013CH05270A publication Critical patent/IN2013CH05270A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN5270CH2013 2013-11-15 2013-11-15 IN2013CH05270A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN5270CH2013 IN2013CH05270A (es) 2013-11-15 2013-11-15

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN5270CH2013 IN2013CH05270A (es) 2013-11-15 2013-11-15

Publications (1)

Publication Number Publication Date
IN2013CH05270A true IN2013CH05270A (es) 2015-09-04

Family

ID=54397745

Family Applications (1)

Application Number Title Priority Date Filing Date
IN5270CH2013 IN2013CH05270A (es) 2013-11-15 2013-11-15

Country Status (1)

Country Link
IN (1) IN2013CH05270A (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021156813A3 (en) * 2020-02-06 2021-09-30 Sifi S.P.A. Xanthan-based ophthalmic topical formulations with a reduced dosage regimen

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021156813A3 (en) * 2020-02-06 2021-09-30 Sifi S.P.A. Xanthan-based ophthalmic topical formulations with a reduced dosage regimen

Similar Documents

Publication Publication Date Title
MX2021000550A (es) Forma de dosis orales de liberacion sostenida de tofacitinib.
EA201592250A1 (ru) Пиразолопирролидиновые производные и их применение в лечение заболеваний
MX2016013529A (es) Derivados de amidas y sales farmaceuticamente aceptables de los mismos, método de preparación de los mismos y aplicación médica de los mismos.
IN2014DN09352A (es)
IN2014DN09348A (es)
EA201591003A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201591751A1 (ru) Трипептидные эпоксикетонные ингибиторы протеазы
NZ756231A (en) A novel isoindoline derivative, a pharmaceutical composition and use thereof
BR112015004499A2 (pt) métodos de administração de terapia de pirfenidona
BR112015009228A8 (pt) Formulação farmacêutica líquida estéril e forma de dosagem intraocular oftálmica líquida estéril para injeção
IN2014DN10548A (es)
EA201491479A1 (ru) Производные лупановых тритерпеноидов и их фармацевтическое применение
IN2013MU00711A (es)
NZ720328A (en) Pyranochromenyl phenol derivative, and pharmaceutical composition for treating metabolic syndrome or inflammatory disease
TN2014000001A1 (en) A new therapeutical composition containing apomorphine as active ingredient
IN2014DN09347A (es)
PH12014501545A1 (en) Stable pharmaceutical formulation for oral administration comprising levocetirizine or a pharmaceutically acceptable salt thereof, and montelukast or a pharmaceutically acceptable salt thereof
EA201400064A1 (ru) Офтальмологическая фармацевтическая композиция для местного применения, которая содержит регорафениб
WO2015009742A3 (en) Compounds and methods for treating cancer, neurological disorders, ethanol withdrawal, anxiety, depression, and neuropathic pain
ECSP15026386A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
GR1008228B (el) Φαρμακευτικο σκευασμα περιεχον ενα διπλο αναστολεα επαναπροσληψης και μεθοδος για την παρασκευη αυτου
IN2013CH05270A (es)
MX2016002502A (es) Composiciones farmaceuticas de bendamustina.
MX362717B (es) Formulaciones de agomelatina que comprenden agomelatina en forma de cocristales.
WO2014007549A3 (ko) 에스-알릴-엘-시스테인을 유효성분으로 포함하는 대장염 예방 또는 치료용 조성물 및 이를 포함하는 의약제제